References
- Haslan DW, James WPT. Obesity. Lancet366, 1197–1209 (2005).
- Roth J, Quiang X, Marban SL, Redelt H, Lowell BC. The obesity pandemic: where have we been and where are we going? Obesity Res.12 (Suppl.), 88–101 (2004).
- Dandona P, Aljada A, Chandhuri A, Mohanty P, Garg R. Metabolic syndrome. A comprehensive perspective based on interaction between obesity, diabetes, and inflammation. Circulation111, 1448–1454 (2005).
- Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia45, 924–930 (2002).
- Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology30, 1–10 (2005).
- Selye H. Syndrome produced by diverse nocuous agents. Nature1, 38–42 (1936).
- Plotsky PM, Cunningham ET, Widmaier EP. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr. Rev.10, 437–445 (1989).
- Hjemdahl P. Stress and the metabolic syndrome. An interesting but enigmating association. Circulation106, 2634–2636 (2002).
- McEwen BS. Protective and damaging effects of stress mediators. N. Engl. J. Med.338, 171–179 (1998).
- Dallman MF, La Fleur SE, Pecoraro NC, Gomez F, Houshyar H, Akana SF. Minireview: glucorticoids-food intake, abdominal obesity, and wealthy nations in 2004. Endocrinology145, 2633–2638 (2004).
- Steiner MA, Wotjack CT. Role of the endocannabinoid system in regulation of the hypothalamic–pituitary–adrenocortical axis. Prog. Brain Res.170, 397–432 (2008).
- Pasquali R, Vicennati V, Gambineri A, Pagotto U. Sex dependent role of glucocorticoids and androgen in the pathophysiology of human obesity. Int. J. Obes. (Lond.)38, 1764–1779 (2008).
- Viau V. Functional cross-talk between the hypothalamic–pituitary–gonadal and –adrenal axes. J. Neuroendocrinol.14, 506–513 (2002).
- Herman JP, Figueireido H, Muller NK et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo–pituitary–adrenocortical responsiveness. Front. Neuroendocrinol.24, 151–180 (2003).
- Tsigos C, Chrousos GP. Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res.53, 865–871 (2002).
- de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci.6, 463–475 (2005).
- Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA267, 1244–1252 (1992).
- Lightman SL. The neuroendocrinology of stress: a never ending story. J. Neuroendocrinol.20, 880–884 (2008).
- Pacak K, Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr. Rev.22, 502–548 (2001).
- Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypotalamo–pituitary–adrenocortical axis. Trends Neurosci.20, 78–84 (1997).
- Herman JP, Ostander MM, Mueller NK, Figueireido H. Lymbic system mechanisms of stress regulation: hypothalamic–pituitary–adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry29, 1201–1213 (2005).
- Pruessner JC, Dedovic K, Pruessner M et al. Stress regulation in the central nervous system: evidence from structural and functional neuroimaging studies in human populations. Psychoneuroendocrinology35(1), 179–191 (2009).
- Dedovic K, Duchesne A, Andrews J, Engert V, Pruessner JC. The brain and the stress axis: the neural correlates of cortisol regulation in response to stress. Neuroimage47(3), 864–871 (2009).
- LeDoux J. The emotional brain, fear, and the amygdala. Cell. Mol. Neurobiol.23, 727–738 (2003).
- Murray EA, Bussey TJ, Saksida IM. Visual perception and memory: a new view of medial temporal lobe function in primates and rodents. Annu. Rev. Neurosci.30, 99–122 (2007).
- Kvetnansky R, Sabban EL, Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol. Rev.89, 535–606 (2009).
- Pruessner JC, Dedovic K, Khalili-Mahani N et al. Deactivation of the limbic system during acute psychosocial stress: evidence from positron emission tomography and functional magnetic resonance imaging studies. Biol. Psychiatry63, 234–240 (2008).
- Liberzon I, Sripada CS. The functional neuroanatomy of PTSD: a critical review. Prog. Brain Res.167, 151–169 (2008).
- Herman JP, Schafer MK-H, Young EA et al. Evidence for hippocampal regulation of the hypotalamic–pituitary–adrenal axis. J. Neurosci.9, 3072–3082 (1989).
- Wolf OT, Convit A, de Leon MJ, Caraos C, Quadri SF. Basal hypothalamic–pituitary–adrenal axis activity and corticotropin feedback in young and older man: relationship to magnetic resonance imaging – derived hippocampus and cingulate gyrus volume. NeuroEndocrinology75, 241–249 (2002).
- Liu D, Diorio J, Tannenbaum B et al. Maternal care, hippocampal glucocorticoid receptors and hypothalamic–pituitary–adrenalresponses to stress. Science277, 1659–1662 (1997).
- Dedovic K, Renwick R, Mahani NK, Engert V, Lupien SJ, Pruessner JC. The Montreal Imaging Stress Task: using functional imaging to investigate the effect of perceiving and processing psychological stress in the human brain. J. Psichiatry Neurosci.30, 319–325 (2005).
- Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev.83, 1017–1066 (2003).
- Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci.4, 873–884 (2003).
- Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology.47 (Suppl. 1), 345–358 (2004).
- Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr. Rev.27, 73–100 (2006).
- Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci.11, 563–583 (1991).
- Dallman MF. Fast glucocorticoid feedback favors ‘the munchies’. Trends Endocrinol. Metab.14, 394–396 (2003).
- Murphy LL, Munoz RM, Adrian BA, Villanua MA. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol. Dis.5, 432–446 (1998).
- Manzanares J, Corchero J, Fuentes JA. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of d(9)-tetrahydrocannabinol in rats. Brain Res.839, 173–179 (1999).
- Weidenfeld J, Feldman S, Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo–pituitary–adrenal axis in the rat. NeuroEndocrinology59, 110–112 (1994).
- Wenger T, Jamali KA, Juaneda C, Leonardelli J, Tramu G. Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. Biochem. Biophys. Res. Commun.237, 724–728 (1997).
- Corchero J, Fuentes JA, Manzanares J. Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat. Life Sci.64, 905–911 (1999).
- Bellocchio L, Cervino C, Pasquali R, Pagotto U. The endocannabinoid system and energy metabolism. J. Neuroendocrinol.20, 850–857 (2008).
- Pagano C, Pilon C, Calcagno et al. The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. J. Clin. Endocrinol. Metab.92, 4810–4819 (2007).
- Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic–pituitary–adrenal axis. Endocrinology145, 5431–5438 (2004).
- Cota D, Steiner MA, Marsicano G et al. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic–pituitary–adrenal axis function. Endocrinology148, 1574–1581 (2007).
- Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet370, 1706–1713 (2007).
- Hill MN, McEwen BS. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog. Neuropsychopharmacol. Biol. Psychiatry DOI: 10.1016/j.pnpbp.2009.11.001 (2009) (Epub ahead of print).
- Haller J, Varga B, Ledent C, Barna I, Freund TF. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur. J. Neurosci.19, 1906–1912 (2004).
- Uriguen L, Perez-Rial S, Ledent C, Palomo T, Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology.46, 966–973 (2004).
- Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci.23, 4850–4857 (2003).
- Shively CA, Register TC, Clarkson TB. Social stress, visceral obesity, and coronary artery atherosclerosis in female primates. Obesity (Silver Spring)17, 1513–1520 (2009).
- Strawn WB, Bondjers G, Kaplan JR et al. Endothelial dysfunction in response to psychosocial stress in monkeys. Circ. Res.68, 1270–1279 (1991).
- Kaplan JR, Manuck SB. Ovarian dysfunction, stress, and disease: a primate continuum. ILAR J.45, 89–115 (2004).
- Bjorntorp P, Rosmond R. Neuroendocrine abnormalities in visceral obesity. Int. J. Obes.24, 580–585 (2000).
- Chrousos GP. Editorial: a healthy body in a healthy mind and vice versa. The damaging power of “uncontrollable” stress. J. Clin. Endocrinol. Metab.83, 1842–1845 (1998).
- Björntorp P. Visceral obesity: a “Civilization Syndrome”. Obes. Res.1, 206–222 (1993).
- Rosmond R, Lapidus L, Marin P, Björntorp P. Mental distress, obesity and body fat distribution in middle-aged women. Obes. Res.4, 245–252 (1996).
- Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic–pituitary–adrenal axis activity in obesity and the metabolic syndrome. Ann. NY Acad. Sci.1083, 111–128 (2006).
- Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc. Natl Acad. Sci. USA98, 4770–4775 (2001).
- Gruenewald TL, Seeman TE, Ryff CD, Karlamangla AS, Singer BH. Combinations of biomarkers predictive of later life mortality. Proc. Natl Acad. Sci. USA103, 14158–14163 (2006).
- Levine AS, Billington CJ. Why do we eat? A neural systems approach. Annu. Rev. Nutr.17, 597–619 (1997).
- Bellar A, Jarosz PA, Bellar D. Implications of the biology of weight regulation and obesity on the treatment of obesity. J. Am. Acad. Nurse Pract.20, 128–135 (2008).
- Porte D Jr, Baskin DG, Schwartz MW. Leptin and insulin action in the central nervous system. Nutr. Rev.60, 20–29 (2002).
- Popkin BM, Duffey K, Gordon-Larsen P. Environmental influences on food choice, physical activity and energy balance. Physiol. Behav.86, 603–613 (2005).
- Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu. Rev. Physiol.67, 259–284 (2005).
- Oliver G, Wardle J, Gibson EL. Stress and food choice: a laboratory study. Psychosom. Med.62, 853–865 (2000).
- Adam TC, Epel ES. Stress, eating and the reward system. Physiol. Behav.91, 449–458 (2007).
- Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite on appetite in women: laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology26, 37–49 (2001).
- Dallman MF, Pecoraro NC, la Fleur SE. Chronic stress and comfort foods: self-medication and abdominal obesity. Brain Behav. Immun.19, 275–280 (2005).
- la Fleur SE, Akana SF, Manalo S, Dallman MF. Interaction between corticosterone and insulin in obesity: regulation of lard intake and fat stores. Endocrinology145, 2174–2185 (2004).
- Bartolomucci A, Cabassi A, Govoni P et al. Metabolic consequences and vulnerability to diet-induced obesity in male mice under chronic social stress. PLoS ONE4, e4331 (2009).
- Kaplan HI, Kaplan HS. The psychosomatic concept of obesity. J. Nerv. Ment. Dis.125, 181–201 (1957).
- Widmaier EP, Rosen K, Abbott B. Free fatty acids activate the hypothalamic–pituitary–adrenocortical axis in rats. Endocrinology131, 2313–2318 (1992).
- Kuo LE, Kitlinska JB, Tilan JU et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med.13, 803–811 (2007).
- Vicennati V, Pasqui F, Cavazza C, Pagotto U, Pasquali R. Stress-related development of obesity and cortisol in women. Obesity (Silver Spring)17, 1676–1683 (2009).
- van Praag HM. Can stress cause depression? Prog. Neuropsychopharmacol. Biol. Psychiatry28, 891–907 (2004).
- Rydmark I, Wahlberg K, Ghatan PH et al. Neuroendocrine, cognitive and structural imaging characteristics of women on longterm sickleave with job stress-induced depression. Biol. Psychiatry60, 867–873 (2006).
- Bartolomucci A, Leopardi R. Stress and depression: preclinical research and clinical implications. PLoS ONE4, e4265 (2009).
- Pasquali R. Obesity and androgens: fact and perspectives. Fertil. Steril.85, 1319–1340 (2006).